Malaria on islands. Human and parasite diversities and implications for malaria control in Vanuatu.
Kaneko
Akira
A
Department of International Affairs and Tropical Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan. akirak@research.twmu.ac.jp
D000818:Animals; D000962:Antimalarials / Q000378:metabolism / Q000627:therapeutic use; D001189:Aryl Hydrocarbon Hydroxylases / Q000172:deficiency / Q000235:genetics; D065731:Cytochrome P-450 CYP2C19; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D014644:Genetic Variation / Q000235:genetics*; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000235:genetics; D006801:Humans; D008658:Inactivation, Metabolic / Q000235:genetics; D008288:Malaria / Q000235:genetics* / Q000469:parasitology* / Q000517:prevention & control; D006899:Mixed Function Oxygenases / Q000172:deficiency / Q000235:genetics; D010961:Plasmodium / Q000235:genetics*; D009514:Vanuatu / Q000453:epidemiology / Q000208:ethnology
D000962:Antimalarials; D006899:Mixed Function Oxygenases; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19